Table 1.

Baseline clinical characteristics

VariableLow-Normal Bone Turnover, No GHLow-Normal Bone Turnover, GHHigh Bone Turnover, Calcitriol, No GHHigh Bone Turnover, Calcitriol, GH
Patients (n)77118
Age (yr)9.5 (2.8, 14.3)8.3 (7.8, 1)12.3 (11.7, 14.5)13.9 (11.4, 15.5)
Male/female (n/n)2/52/57/44/4
Ethnicity1
 White1312
 Black6391
 Hispanic14
 Asian1
Time on dialysis (yr)0.6 (0.4, 1.2)0.3 (0.2, 0.8)0.4 (0.3, 0.6)0.4 (0.3, 0.8)
Patients receiving calcitriol before the 4-week washout, n (%)3 (43)2 (29)3 (43)2 (25)
Prepubertal patients, n (%)a4 (57)4 (57)5 (45)4 (50)
Z-score body weight−1.8 (−2.8, −1.6)−1.1 (−1.9, −0.7)−1.2 (−1.9, −0.6)−1.5 (−2.3, −0.7)
Z-score height−2.6 (−3.9, −1.0)−2.3 (−2.7, −1.7)−2.1 (−2.2, −1.3)−2.3 (−3.3, −1.3)
  • a Prepubertal patients: Tanner stage 1; pubertal patients: Tanner stage 2–5.